Covid-19. COVID 19, virus identified
Conditions
Sponsors
Imam Khomeini Hospital, Tehran
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: To participate in the study, patients, or their legal guardian must give their knowing and voluntary consent in writing and orally The PCR test for SARS-CoV-2 virus must be positive with one of the following conditions: signs indicating covid-19 disease such as fever, dry cough and shortness of breath CT scan (HRCT or Spiral CT) to show coronavirus involvement, specifically in the ground glass view in the peripheral or basal portions of the lungs and physician's confirmation Patients who have signs of medical conditions secondary to covid-19 infection such as Acute Respiratory Distress Syndrome (ARDS) or myocarditis Patients should not have taken antiretroviral or boosters of immune system up to 3 months prior to the start of the study
Exclusion criteria
Exclusion criteria: Patients will not participate in this study during pregnancy or lactation Patients whose covid-19 infection has not been confirmed but have cold or flu-like symptoms. Current use of stimulants or depressant drugs or alcohol Use of growth hormone, testosterone or anabolic steroids up to 30 days prior to the start of the study Long-term treatment with immunosuppressant medications except topical steroids Patients undergoing chemotherapy, radiotherapy (up to 3 weeks prior to the start of the experiment) or patients who have been prescribed interferon
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood test (CBC, Diff-ESR-CRP-Ast-Alt-Cr-D Dimer). Timepoint: At the beginning, and after 14 days at the end of the study. Method of measurement: Blood Test CBC, (Diff-ESR-CRP-Ast-Alt-Cr-D Dimer). | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical manifestations: Respiratory symptoms or common acute and non-respiratory symptoms such as lethargy, fever, myalgia, dry cough, phlegm, diarrhea, shortness of breath, rhinitis, vomiting, headaches, chills. Timepoint: daily for 14 days. Method of measurement: Physician's examination, patients answers, information recorded in patient files. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Ahmad Alinaghi, M.D.
Imam Khomeini Hospital, Tehran
Outcome results
None listed